These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17486554)

  • 21. Fluorinated carbohydrates as lectin ligands: versatile sensors in 19F-detected saturation transfer difference NMR spectroscopy.
    Diercks T; Ribeiro JP; Cañada FJ; André S; Jiménez-Barbero J; Gabius HJ
    Chemistry; 2009 Jun; 15(23):5666-8. PubMed ID: 19388026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiotetrazole alkynylacetanilides as potent and bioavailable non-nucleoside inhibitors of the HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases.
    Gagnon A; Amad MH; Bonneau PR; Coulombe R; DeRoy PL; Doyon L; Duan J; Garneau M; Guse I; Jakalian A; Jolicoeur E; Landry S; Malenfant E; Simoneau B; Yoakim C
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4437-41. PubMed ID: 17583503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyrazole NNRTIs 1: design and initial optimisation of a novel template.
    Mowbray CE; Burt C; Corbau R; Perros M; Tran I; Stupple PA; Webster R; Wood A
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5599-602. PubMed ID: 19709880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo.
    Smits RA; Lim HD; Hanzer A; Zuiderveld OP; Guaita E; Adami M; Coruzzi G; Leurs R; de Esch IJ
    J Med Chem; 2008 Apr; 51(8):2457-67. PubMed ID: 18357976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New antivirals and drug resistance.
    Colman PM
    Annu Rev Biochem; 2009; 78():95-118. PubMed ID: 19254207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel HCV RNA-dependent RNA polymerase inhibitors using pharmacophore-guided virtual screening.
    Kim J; Kim KS; Kim DE; Chong Y
    Chem Biol Drug Des; 2008 Dec; 72(6):585-91. PubMed ID: 19090925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and anti-HIV activity of 4'-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors.
    Boojamra CG; Parrish JP; Sperandio D; Gao Y; Petrakovsky OV; Lee SK; Markevitch DY; Vela JE; Laflamme G; Chen JM; Ray AS; Barron AC; Sparacino ML; Desai MC; Kim CU; Cihlar T; Mackman RL
    Bioorg Med Chem; 2009 Feb; 17(4):1739-46. PubMed ID: 19179082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of (1)H NMR to facilitate solubility measurement for drug discovery compounds.
    Lin M; Tesconi M; Tischler M
    Int J Pharm; 2009 Mar; 369(1-2):47-52. PubMed ID: 19073245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.
    Billamboz M; Bailly F; Barreca ML; De Luca L; Mouscadet JF; Calmels C; Andréola ML; Witvrouw M; Christ F; Debyser Z; Cotelle P
    J Med Chem; 2008 Dec; 51(24):7717-30. PubMed ID: 19053754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ranking of high-affinity ligands by NMR spectroscopy.
    Zhang X; Sänger A; Hemmig R; Jahnke W
    Angew Chem Int Ed Engl; 2009; 48(36):6691-4. PubMed ID: 19650100
    [No Abstract]   [Full Text] [Related]  

  • 32. A multidisciplinary approach for the identification of novel HIV-1 non-nucleoside reverse transcriptase inhibitors: S-DABOCs and DAVPs.
    Radi M; Falciani C; Contemori L; Petricci E; Maga G; Samuele A; Zanoli S; Terrazas M; Castria M; Togninelli A; Esté JA; Clotet-Codina I; Armand-Ugón M; Botta M
    ChemMedChem; 2008 Apr; 3(4):573-93. PubMed ID: 18081133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragment-based screening using X-ray crystallography and NMR spectroscopy.
    Jhoti H; Cleasby A; Verdonk M; Williams G
    Curr Opin Chem Biol; 2007 Oct; 11(5):485-93. PubMed ID: 17851109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revealing interaction mode between HIV-1 reverse transcriptase and diaryltriazine analog inhibitor.
    Li Z; Han J; Chen HF
    Chem Biol Drug Des; 2008 Nov; 72(5):350-9. PubMed ID: 19012571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of allosteric PIF-pocket ligands for PDK1 using NMR-based fragment screening and 1H-15N TROSY experiments.
    Stockman BJ; Kothe M; Kohls D; Weibley L; Connolly BJ; Sheils AL; Cao Q; Cheng AC; Yang L; Kamath AV; Ding YH; Charlton ME
    Chem Biol Drug Des; 2009 Feb; 73(2):179-88. PubMed ID: 19207420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Docking and quantitative structure-activity relationship studies for the bisphenylbenzimidazole family of non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Lagos CF; Caballero J; Gonzalez-Nilo FD; David Pessoa-Mahana C; Perez-Acle T
    Chem Biol Drug Des; 2008 Nov; 72(5):360-9. PubMed ID: 19012572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMR in pharmacokinetic and pharmacodynamic profiling.
    Sun C; Huth JR; Hajduk PJ
    Chembiochem; 2005 Sep; 6(9):1592-600. PubMed ID: 16052607
    [No Abstract]   [Full Text] [Related]  

  • 38. NMR-based screening: a powerful tool in fragment-based drug discovery.
    Klages J; Coles M; Kessler H
    Analyst; 2007 Jul; 132(7):693-705. PubMed ID: 17657909
    [No Abstract]   [Full Text] [Related]  

  • 39. Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptase.
    Sweeney ZK; Harris SF; Arora SF; Javanbakht H; Li Y; Fretland J; Davidson JP; Billedeau JR; Gleason SK; Hirschfeld D; Kennedy-Smith JJ; Mirzadegan T; Roetz R; Smith M; Sperry S; Suh JM; Wu J; Tsing S; Villaseñor AG; Paul A; Su G; Heilek G; Hang JQ; Zhou AS; Jernelius JA; Zhang FJ; Klumpp K
    J Med Chem; 2008 Dec; 51(23):7449-58. PubMed ID: 19007201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct detection of ligand binding to Sepharose-immobilised protein using saturation transfer double difference (STDD) NMR spectroscopy.
    Haselhorst T; Münster-Kühnel AK; Oschlies M; Tiralongo J; Gerardy-Schahn R; von Itzstein M
    Biochem Biophys Res Commun; 2007 Aug; 359(4):866-70. PubMed ID: 17574211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.